An Integrated Understanding of the Molecular Mechanisms of How Adipose Tissue Metabolism Affects Long-term Body Weight Maintenance.


Journal

Diabetes
ISSN: 1939-327X
Titre abrégé: Diabetes
Pays: United States
ID NLM: 0372763

Informations de publication

Date de publication:
01 2019
Historique:
received: 16 04 2018
accepted: 22 10 2018
pubmed: 6 11 2018
medline: 26 3 2019
entrez: 4 11 2018
Statut: ppublish

Résumé

Lifestyle-based weight loss interventions frequently demonstrate long-term inefficiency and weight regain. Identification of underlying mechanisms and predictors to identify subjects who will benefit from lifestyle-based weight loss strategies is urgently required. We analyzed 143 adults of the randomized Maintain trial (Maintain-Adults) after intended weight loss to identify mechanisms contributing to the regulation of body weight maintenance. Unbiased RNA sequencing of adipose and skeletal muscle biopsies revealed fatty acid metabolism as a key pathway modified by weight loss. Variability of key enzymes of this pathway, estimates of substrate oxidation, and specific serum acylcarnitine (AC) species, representing a systemic snapshot of in vivo substrate flux, predicted body weight maintenance (defined as continuous or dichotomized [< or ≥3% weight regain] variable) 18 months after intended weight loss in the entire cohort. Key results were confirmed in a similar randomized controlled trial in 137 children and adolescents (Maintain-Children), which investigated the same paradigm in a pediatric cohort. These data suggest that adaption of lipid utilization in response to negative energy balance contributes to subsequent weight maintenance. Particularly a functional role for circulating ACs, which have been suggested to reflect intracellular substrate utilization, as mediators between peripheral energy stores and control of long-term energy homeostasis was indicated.

Identifiants

pubmed: 30389745
pii: db18-0440
doi: 10.2337/db18-0440
doi:

Substances chimiques

acylcarnitine 0
Carnitine S7UI8SM58A

Banques de données

ClinicalTrials.gov
['NCT00850629']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

57-65

Informations de copyright

© 2018 by the American Diabetes Association.

Auteurs

Knut Mai (K)

Department of Endocrinology and Metabolism, Charité-Universitätsmedizin Berlin, Berlin, Germany knut.mai@charite.de.
Charité-Center for Cardiovascular Research, Berlin, Germany.
Clinical Research Unit, Berlin Institute of Health, Berlin, Germany.
German Centre for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.

Linna Li (L)

Department of Endocrinology and Metabolism, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Clinical Research Unit, Berlin Institute of Health, Berlin, Germany.
German Centre for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.

Susanna Wiegand (S)

Department of Pediatric Endocrinology and Diabetology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Maria Brachs (M)

Department of Endocrinology and Metabolism, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Charité-Center for Cardiovascular Research, Berlin, Germany.

Verena Leupelt (V)

Department of Endocrinology and Metabolism, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Charité-Center for Cardiovascular Research, Berlin, Germany.

Andrea Ernert (A)

Department of Pediatric Endocrinology and Diabetology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Peter Kühnen (P)

Department of Pediatric Endocrinology and Diabetology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Norbert Hübner (N)

German Centre for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.
Max Delbrück Center for Molecular Medicine, Berlin, Germany.

Peter Robinson (P)

Institute for Medical Genetics, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Wei Chen (W)

Max Delbrück Center for Molecular Medicine, Berlin, Germany.

Heiko Krude (H)

Department of Pediatric Endocrinology and Diabetology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Joachim Spranger (J)

Department of Endocrinology and Metabolism, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Charité-Center for Cardiovascular Research, Berlin, Germany.
Clinical Research Unit, Berlin Institute of Health, Berlin, Germany.
German Centre for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH